Menu

Report Library

All Reports

Antibiotics Report, Part III: The Outpatient Antibiotics Market

January 29, 2015

This report, the third in our series on antibiotics, describes the drug markets for community-acquired pneumonia (CAP) and gonorrhea. This report provides analysis on the following topics:
  • Common types of outpatient infections, including a discussion of causative pathogens, current treatments, and perspectives on potential markets for agents.
  • Analysis of branded drugs and drugs in development for outpatient infections, along with perspectives on approvability and targeted treatment subgroups.
The first report in this series provided introductory material on antibiotic development through the years, background of the general epidemiology of infections, and a primer on mechanisms of antibiotic resistance. The second report in this series provided analysis on the market for serious inpatient or healthcare-associated infections.

For the full report, please download the PDF version at the top of this page. A listing of upcoming market catalysts is available (below the PDF link) to subscribers as a supplemental file.

For our disclosures, please read the BioMedTracker Research Standards. This report was written in collaboration with Tucker BioPharma Consulting.
Disease Group Covered: Infectious Disease

 Additional Resources: